Mitral Valve Replacement
10
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Abbott Cephea Mitral Valve Disease Registry
Comparative Effects of MIIT With CT In Post-MVR Surgery Patients
CardioLogical Interventions and Acute strOke Treatment sTudy
MITRIS China Post Market Clinical Follow-up (PMCF) Study
The Choice of Mitral Valve Surgery Type and Mid-term Outcomes in Patients up to 70-years: Results of the AUTHEARTVISIT Study
HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
Outcomes of Complete Versus Partial Preservation of the Sub-valvular Apparatus in Cases of Mitral Valve Replacement
Outcome of Preserved Mitral Valve Apparatus During Mitral Valve Replacement
Blood Transfusion Management in Patients With Mitral Valve Replacement in China